Ito Hiroshi, Hosomi Sanae, Koyama Yoshihisa, Matsumoto Hisatake, Imamura Yukio, Ogura Hiroshi, Oda Jun
Department of Traumatology and Acute Critical Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
Front Aging Neurosci. 2022 May 27;14:912866. doi: 10.3389/fnagi.2022.912866. eCollection 2022.
Sepsis is defined as a life-threatening multi-organ dysfunction triggered by an uncontrolled host response to infectious disease. Systemic inflammation elicited by sepsis can cause acute cerebral dysfunction, characterized by delirium, coma, and cognitive dysfunction, known as septic encephalopathy. Recent evidence has reported the underlying mechanisms of sepsis. However, the reasons for the development of inflammation and degeneration in some brain regions and the persistence of neuroinflammation remain unclear. This mini-review describes the pathophysiology of region-specific inflammation after sepsis-associated encephalopathy (SAE), clinical features, and future prospects for SAE treatment. The hippocampus is highly susceptible to inflammation, and studies that perform treatments with antibodies to cytokine receptors, such as interleukin-1β, are in progress. Future development of clinically applicable therapies is expected.
脓毒症被定义为由宿主对传染病的失控反应引发的危及生命的多器官功能障碍。脓毒症引发的全身炎症可导致急性脑功能障碍,其特征为谵妄、昏迷和认知功能障碍,即脓毒症脑病。最近有证据报道了脓毒症的潜在机制。然而,一些脑区发生炎症和变性以及神经炎症持续存在的原因仍不清楚。这篇小型综述描述了脓毒症相关性脑病(SAE)后区域特异性炎症的病理生理学、临床特征以及SAE治疗的未来前景。海马体对炎症高度敏感,目前正在进行使用细胞因子受体抗体(如白细胞介素-1β)进行治疗的研究。预计未来会开发出临床适用的疗法。